Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

Share Price is delayed by 15 minutes
Get Live Data
175.00    0.00 (0.00%)
Bid:
170.00
Ask:
180.00
Spread: 10.00 (5.882%)
Market Cap: £3.25m
NBB Live PriceLast checked at - London Stock Exchange

Intraday Norman Broadb Share Chart

Directorate Change

20 Apr 2026 07:00

RNS Number : 0182B
Norman Broadbent PLC
20 April 2026
Β 

Norman Broadbent plc

("Norman Broadbent", or the "Company")

Β 

Directorate Change

Norman Broadbent (LSE AIM: NBB), a leading Executive Search and Interim Management firm, announces the

appointment of Dr. Annette Nabavi to the Board as an independent non-executive director with effect from 1 May 2026 with Annette assuming the roles of Chair of the Remuneration Committee and member of the Audit Committee upon appointment.Β 

Β 

Annette brings over 30 years of experience in operational and advisory roles including driving growth through team building and international diversification, and through acquisition and partnerships. Annette currently sits on the boards of Eleco plc and Iomart Group plc, two AIM companies. At Eleco, Annette is Senior Independent Director, Chair of the Remuneration Committee and is a member of the Audit & Risk, the Nominations and the Environmental, Social & Governance Committees. At Iomart, Annette is Chair of the Remuneration Committee and is a member of the Audit and the Nominations Committees. She has held several other non-executive director roles, including at Maintel Holdings Plc, where she also chaired the Remuneration Committee. Her remuneration experience is also reflected in her involvement with the Quoted Companies Alliance (QCA), where she supported the update to the Remuneration Committee Guide published in 2021. Annette is Finance Director for Women in Telecoms and Technology, a Not-for-Profit organisation.

Β 

Peter Searle, Chairman of Norman, Broadbent said: "Annette is an accomplished business leader who brings highly relevant and valuable expertise to the Norman Broadbent Board. Her broad operational and advisory background is complemented by her specialist remuneration skillset and extensive experience as a NED. We are delighted to welcome Annette to the Board. To attract someone with her pedigree speaks volumes for the significant opportunity we have ahead."

Β 

Annette Nabavi, commented: "I am delighted to be joining Norman Broadbent at this exciting stage in its journey as a listed business. Norman Broadbent has not only weathered the storm of a difficult market environment over the last few years, but under its proven leadership team, the business has been transformed as a market leading executive search firm with broader capabilities. The business is in good shape financially and, with a clear strategy based on disciplined organic investment and M&A, I look forward to supporting the team to drive the next stage of growth."

Β 

The Board is looking to appoint a further independent non-executive director in due course. Further announcements will be made as appropriate.Β 

Β 

Appendix

Β 

Pursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies, the following information is disclosed in respect of Annette Nabavi:Β 

Β 

The following additional information is provided with regards to the appointment of Annette Patricia Nabavi (nΓ©e Lane), aged 74, in accordance with Rule 17 and Schedule 2(g) of the AIM Rules for Companies:

Β 

Current Directorships

Previous Directorships held in the past five years

Eleco plc

Iomart Group plc

Women in Telecoms and Technology (WITT) Ltd

Β 

EFI Group Ltd

Maintel Group plc

Anchusa Consulting Ltd

Talan UK & Ireland Limited

Β 

Β 

Dr. Nabavi does not hold any shares, options or warrants in the Company as at the date of this announcement.

Β 

There is no further information regarding Dr. Nabavi required to be disclosed under the AIM Rules.

Β 

For further information please contact:

Β 

Norman Broadbent plcΒ 

+44Β (0)20 7484 0000

Kevin Davidson, CEOΒ 

Mehr Malik, CFO

Β 

Cavendish Capital Markets Limited

+44 (0)20 7220 0500

Nominated Adviser and Sole Broker

Julian Blunt, Seamus Fricker,Β Andrea Callaghan - Corporate Finance

Jasper Berry, Matt Lewis - Sales / Corporate Broking

Gracechurch Group

+44 (0)20 4582 3500

Financial Media & Investor Relations

normanbroadbent@gracechurchpr.com

Murdo Montgomery

Tommy Bryson

Anysia Virdi

Β Β 

About Norman Broadbent:

Β 

Norman Broadbent (AIM: NBB) is a professional services firm focused on executive search, senior interim management solutions and bespoke leadership advisory services working across the UK and internationally.

 ​ 

Established as the first UK-headquartered search firm in 1979, the firm has a 40+ year track record of shaping leadership across industries including Consumer, Financial Services, Industrials, Life Sciences, Investor and TMT.

Β 

www.normanbroadbent.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAGPUGUCUPQGPB
Date   Source Headline
20th Mar 20241:36 pmRNSNotice of Results & Investor Presentation
18th Mar 20244:33 pmRNSNotification of major holdings
18th Mar 20244:04 pmRNSNotification of major holdings
12th Mar 20243:33 pmRNSAIM Rule 17 Schedule Two (g) Update
22nd Jan 20245:32 pmRNSNotification of Major Holdings
16th Jan 20247:00 amRNSTrading Update
21st Nov 202310:06 amRNSNotification of Major Holdings
20th Nov 202310:45 amRNSDirector/PDMR shareholding
15th Nov 20239:54 amRNSNotification of Major Holdings
15th Nov 20239:43 amRNSNotification of Major Holdings
10th Nov 20237:00 amRNSDirector/PCA Dealing
9th Nov 20232:25 pmRNSDirector/PDMR Shareholding
2nd Nov 20238:43 amRNSConversion Of Outstanding Convertible Loan Notes
12th Oct 20237:00 amRNSQ3 2023 Trading Update
10th Oct 202311:03 amRNSNotification of Major Holdings
9th Oct 20237:00 amRNSSurrender and Granting of Options
28th Jul 20237:00 amRNSGrant of Options
24th Jul 20237:00 amRNSInterim Results
11th Jul 20237:00 amRNSH1 2023 Trading Update
30th Jun 20237:00 amRNSSAYE Option Plan & Director Holding
29th Jun 20234:28 pmRNSResult of AGM
5th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
1st Jun 20237:00 amRNSDirectorate changes
31st May 20237:00 amRNSFinal Results
22nd May 20237:00 amRNSQ1 2023 Trading Update
19th May 202312:55 pmRNSPartial Repayment of Convertible Loan Note
24th Jan 20237:00 amRNSTrading Update
10th Jan 20237:00 amRNSDirectorate Change
17th Nov 20224:42 pmRNSTR-1: Notification of major holdings
14th Nov 20227:00 amRNSIssue of Equity
1st Nov 20227:00 amRNSUpdate and Change of Board role
10th Oct 20225:30 pmRNSTR-1: Notification of major holdings
31st Aug 20227:00 amRNSDirector Share Purchase
23rd Aug 20227:00 amRNSDirectorate Change
16th Aug 20227:00 amRNSInterim Results
29th Jul 20227:00 amRNSChange of Adviser
20th Jul 20224:08 pmRNSDirector/PDMR Dealing
11th Jul 20227:00 amRNSTrading Update
29th Jun 20223:15 pmRNSDirector/PDMR Shareholding
23rd Jun 202212:14 pmRNSResult of AGM
7th Jun 20228:59 amRNSHolding(s) in Company
25th May 20227:00 amRNSFinal 2021 Results and Notice of AGM
20th May 20225:49 pmRNSIssue of Convertible Loan Notes
11th May 20224:16 pmRNSDirector resignation
18th Mar 20227:00 amRNSGrant of Options to Directors and Employees
2nd Mar 20227:00 amRNSFY2021 Trading Update
7th Feb 20227:00 amRNSBoard Changes
7th Dec 20213:50 pmRNSHolding(s) in Company
6th Dec 202110:18 amRNSSubscription
2nd Dec 20217:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.